Alex MacKerell, PhD, SilcsBio Co-founder & CSO, Co-Leads Study on Use of SILCS Technology to Improve Lung Disease Treatments

Article in Proceedings of the National Academy of Sciences illustrates use of SILCS mapping technology to improve treatments for asthma and chronic obstructive pulmonary disease December 14, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced its Co-Founder [...]

December 14th, 2022|
Go to Top